Sharps Compliance (NASDAQ:SMED) Share Price Passes Above 200 Day Moving Average of $0.00

Shares of Sharps Compliance Corp. (NASDAQ:SMED) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $3.82. Sharps Compliance shares last traded at $3.82, with a volume of 121 shares traded.

A number of analysts recently commented on SMED shares. Roth Capital started coverage on shares of Sharps Compliance in a research note on Wednesday, July 24th. They issued a “buy” rating and a $4.50 target price for the company. Robert W. Baird assumed coverage on shares of Sharps Compliance in a research report on Wednesday, July 24th. They set a “buy” rating and a $4.50 price target for the company. Zacks Investment Research lowered shares of Sharps Compliance from a “hold” rating to a “strong sell” rating in a research report on Saturday, May 25th. Finally, Barrington Research reissued a “buy” rating and set a $4.50 price target on shares of Sharps Compliance in a research report on Tuesday, May 21st.

The company has a debt-to-equity ratio of 0.04, a current ratio of 2.49 and a quick ratio of 1.95. The stock has a market capitalization of $62.96 million, a PE ratio of -95.00, a PEG ratio of 1.66 and a beta of 0.24. The company’s fifty day moving average is $3.59.

In related news, Director Parris H. Holmes, Jr. purchased 40,000 shares of the business’s stock in a transaction that occurred on Thursday, June 13th. The stock was bought at an average price of $3.31 per share, with a total value of $132,400.00. Following the acquisition, the director now owns 942,027 shares in the company, valued at $3,118,109.37. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last three months, insiders purchased 46,250 shares of company stock valued at $153,075. 20.70% of the stock is owned by insiders.

An institutional investor recently raised its position in Sharps Compliance stock. Lapides Asset Management LLC grew its holdings in shares of Sharps Compliance Corp. (NASDAQ:SMED) by 13.3% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 164,700 shares of the industrial products company’s stock after purchasing an additional 19,300 shares during the quarter. Lapides Asset Management LLC owned approximately 1.02% of Sharps Compliance worth $586,000 at the end of the most recent quarter. 19.81% of the stock is currently owned by institutional investors.

Sharps Compliance Company Profile (NASDAQ:SMED)

Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.

Read More: Why investors pay attention to retained earnings

Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with's FREE daily email newsletter.